Quest PharmaTech Inc (QPT) - Total Liabilities

Latest as of October 2025: CA$1.25 Million CAD ≈ $907.03K USD

Based on the latest financial reports, Quest PharmaTech Inc (QPT) has total liabilities worth CA$1.25 Million CAD (≈ $907.03K USD) as of October 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore QPT cash flow metrics to assess how effectively this company generates cash.

Quest PharmaTech Inc - Total Liabilities Trend (1998–2025)

This chart illustrates how Quest PharmaTech Inc's total liabilities have evolved over time, based on quarterly financial data. Check Quest PharmaTech Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Quest PharmaTech Inc Competitors by Total Liabilities

The table below lists competitors of Quest PharmaTech Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Absolicon Solar Collector AB Series B ST:ABSL-B	Sweden	Skr5.11 Million
Hapbee Technologies Inc V:HAPB	Canada	CA$3.86 Million
Wyncoast Industrial Park Public Company Limited BK:WIN	Thailand	฿352.93 Million
IQE PLC LSE:IQE	UK	GBX122.20 Million
Conferize A/S CO:CONFRZ	Denmark	Dkr2.65 Million
Cerillion PLC LSE:CER	UK	GBX15.66 Million
Samchai Steel Industries Public Company Limited BK:SAM	Thailand	฿2.41 Billion
Golden Metal Resources PLC LSE:GMET	UK	GBX1.78 Million

Liability Composition Analysis (1998–2025)

This chart breaks down Quest PharmaTech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Quest PharmaTech Inc market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.07	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.05	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Quest PharmaTech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Quest PharmaTech Inc (1998–2025)

The table below shows the annual total liabilities of Quest PharmaTech Inc from 1998 to 2025.

Year	Total Liabilities	Change
2025-01-31	CA$1.17 Million ≈ $845.16K	-11.67%
2024-01-31	CA$1.32 Million ≈ $956.88K	+19.56%
2023-01-31	CA$1.11 Million ≈ $800.36K	+77.71%
2022-01-31	CA$622.60K ≈ $450.38K	+59.87%
2021-01-31	CA$389.44K ≈ $281.72K	-98.14%
2020-01-31	CA$20.95 Million ≈ $15.15 Million	+106.50%
2019-01-31	CA$10.14 Million ≈ $7.34 Million	+1.95%
2018-01-31	CA$9.95 Million ≈ $7.20 Million	+1256.57%
2017-01-31	CA$733.49K ≈ $530.60K	-94.49%
2016-01-31	CA$13.30 Million ≈ $9.62 Million	+227.17%
2015-01-31	CA$4.07 Million ≈ $2.94 Million	+22.68%
2014-01-31	CA$3.31 Million ≈ $2.40 Million	+95445.89%
1998-01-31	CA$3.47K ≈ $2.51K	--

About Quest PharmaTech Inc

V:QPT Canada Biotechnology

Market Cap

$4.89 Million

CA$6.77 Million CAD

Market Cap Rank

#28402 Global

#1293 in Canada

Share Price

CA$0.04

Change (1 day)

+0.00%

52-Week Range

CA$0.03 - CA$0.06

All Time High

CA$0.25